Form 4: Revolution Medicines Director Sells Shares
Insider Transaction (Form 4)
Elizabeth M Anderson, a Director of Revolution Medicines, Inc., sold 10,143 shares of common stock on September 22, 2026.
Summary
- Option exercise/conversion: acquired 5,070 Common Stock at $1.12 ($5,678) on September 22, 2026; holds 14,476 after (Direct).
- Open-market sale: disposed of 910 Common Stock at $191.85 ($174,585) on September 22, 2026; holds 13,566 after (Direct).
- Open-market sale: disposed of 4,985 Common Stock at $192.54 ($959,805) on September 22, 2026; holds 8,581 after (Direct).
- Open-market sale: disposed of 2,648 Common Stock at $193.44 ($512,227) on September 22, 2026; holds 5,933 after (Direct).
- Open-market sale: disposed of 1,500 Common Stock at $194.59 ($291,883) on September 22, 2026; holds 4,433 after (Direct).
- Open-market sale: disposed of 100 Common Stock at $195.15 ($19,515) on September 22, 2026; holds 4,333 after (Direct).
- Option exercise/conversion: disposed of 5,070 Stock Option (Right to Buy) on September 22, 2026; holds 1,095 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,958,016 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Elizabeth M Anderson — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-22 | Option exercise/conversion | Common Stock | 5,070 | $1 | $5.7K | 14,476 |
| 2026-09-22 | Open-market sale | Common Stock | 910 | $192 | $174.6K | 13,566 |
| 2026-09-22 | Open-market sale | Common Stock | 4,985 | $193 | $959.8K | 8,581 |
| 2026-09-22 | Open-market sale | Common Stock | 2,648 | $193 | $512.2K | 5,933 |
| 2026-09-22 | Open-market sale | Common Stock | 1,500 | $195 | $291.9K | 4,433 |
| 2026-09-22 | Open-market sale | Common Stock | 100 | $195 | $19.5K | 4,333 |
| 2026-09-22 | Option exercise/conversion | Stock Option (Right to Buy) | 5,070 | — | — | 1,095 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-22 | Option exercise/conversion (5,070 shares) |
| 2026-09-22 | Open-market sale (910 shares) |
| 2026-09-22 | Open-market sale (4,985 shares) |
| 2026-09-22 | Open-market sale (2,648 shares) |
| 2026-09-22 | Open-market sale (1,500 shares) |
| 2026-09-22 | Open-market sale (100 shares) |
| 2026-09-22 | Option exercise/conversion (5,070 shares) |
Keywords
insider transaction, Form 4, RVMD, Revolution Medicines, Inc., bearish, Elizabeth M Anderson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.